SCHEMBL6478196

SCHEMBL6478196

CC(C)OC(=O)c1cn[nH]c1-c1cc2ccccc2[nH]1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.55
LMNA P02545 1/20 0.55
TP53 P04637 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
ALDH1A1 P00352 4/20 0.46
HPGD P15428 2/20 0.46
HSD17B10 Q99714 1/20 0.46
BRD4 O60885 1/20 0.43
ITK Q08881 3/20 0.42
CCNE1 P24864 1/20 0.42
CDK2 P24941 1/20 0.42
GSK3B P49841 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
AURKA O14965 1/20 0.39
AURKB Q96GD4 1/20 0.39
SYK P43405 1/20 0.38
RAB9A P51151 3/20 0.38
ADORA3 P0DMS8 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5755243 0.86 ITK (0.46) KDM4ELMNATP53L3MBTL1ALDH1A1
SCHEMBL6488207 0.85 ALDH1A1 (0.49) KDM4ELMNATP53L3MBTL1ALDH1A1
SCHEMBL5755157 0.83 DCAF1 (0.45) BRD4ITKCCNE1CDK2GSK3B
SCHEMBL5756183 0.83 ALDH1A1 (0.48) KDM4ELMNAL3MBTL1ALDH1A1HPGD
SCHEMBL6489610 0.81 KDM4E (0.48) KDM4ELMNATP53L3MBTL1ALDH1A1
SCHEMBL5756205 0.81 KDM4E (0.47) KDM4EHPGDHSD17B10BRD4ITK
SCHEMBL5754202 0.80 CHEK1 (0.46) KDM4EHPGDHSD17B10BRD4ITK
SCHEMBL6478111 0.80 ALDH1A1 (0.50) KDM4ELMNATP53L3MBTL1ALDH1A1
SCHEMBL5756905 0.79 BRD4 (0.45) KDM4ELMNATP53ALDH1A1HPGD
SCHEMBL5753389 0.78 ITK (0.44) LMNAHSD17B10BRD4ITKCCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K9, MAP3K20, MAP3K19 KDM4E 765/4885LMNA 2918/4885TP53 317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.